Trends in Antibody-Drug Conjugates (ADCs): The 2025 Breakthroughs
The "ADC Revolution" has reached a tipping point in 2025, transitioning from a niche oncology tool to a mainstream therapeutic modality. An updated Antibodies Market Trend report notes that the ADC segment is growing at a CAGR of 16.8%, far outpacing the general pharmaceutical market. The most significant breakthrough in 2025 is the expansion of ADCs into Non-Oncology Indications, including...
0 التعليقات 0 المشاركات 6 مشاهدة 0 معاينة